ArticlesFull Access
Published Online:6 Nov 2015https://doi.org/10.1176/appi.ajp.2015.15020164
- Cited by
- 19 April 2024 | Journal of Clinical Psychopharmacology, Vol. 20
- 12 April 2024 | Bipolar Disorders, Vol. 66
- 20 September 2023 | International Clinical Psychopharmacology, Vol. 39, No. 2
- Journal of Affective Disorders, Vol. 347
- 20 September 2023 | International Clinical Psychopharmacology, Vol. 39, No. 1
- 15 March 2024 | European Psychiatry, Vol. 67, No. 1
- 27 November 2023 | Frontiers in Psychiatry, Vol. 14
- 13 September 2023 | Healthcare, Vol. 11, No. 18
- 26 February 2023 | Bipolar Disorders, Vol. 25, No. 6
- Journal of Child and Adolescent Psychopharmacology, Vol. 33, No. 6
- European Neuropsychopharmacology, Vol. 72
- 25 May 2023 | Drugs, Vol. 83, No. 10
- Journal of Affective Disorders, Vol. 333
- 13 March 2023 | International Clinical Psychopharmacology, Vol. 38, No. 4
- 30 August 2023 | Analytical Chemistry Letters, Vol. 13, No. 3
- Asian Journal of Psychiatry, Vol. 82
- Journal of Affective Disorders, Vol. 26
- Gary S. Sachs,
M.D. , - Paul P. Yeung,
M.D., M.P.H. , - Ludmyla Rekeda,
Ph.D. , - Arifulla Khan,
M.D. , - Julie L. Adams,
M.D., M.P.H. , - Maurizio Fava,
M.D.
15 February 2023 | American Journal of Psychiatry, Vol. 180, No. 3- Gary S. Sachs,
- European Neuropsychopharmacology, Vol. 68
- CNS & Neurological Disorders - Drug Targets, Vol. 22, No. 2
- 14 January 2023 | World Psychiatry, Vol. 22, No. 1
- Journal of Child and Adolescent Psychopharmacology, Vol. 32, No. 8
- Psiquiatría Biológica, Vol. 29, No. 3
- 1 August 2022 | Frontiers in Psychiatry, Vol. 13
- 13 February 2022 | Australasian Psychiatry, Vol. 30, No. 3
- Biological Psychiatry, Vol. 91, No. 9
- Journal of Affective Disorders, Vol. 302
- 17 March 2022 | Frontiers in Psychiatry, Vol. 13
- 24 January 2022 | Journal of Clinical Psychopharmacology, Vol. 42, No. 2
- 23 February 2022 | CNS Spectrums, Vol. 11
- 6 February 2022 | International Journal of Molecular Sciences, Vol. 23, No. 3
- 15 January 2022 | Consortium Psychiatricum, Vol. 3, No. 1
- 26 June 2021 | Journal of Addictive Diseases, Vol. 40, No. 1
- 1 May 2022 | Neuropsychiatric Disease and Treatment, Vol. Volume 18
- 17 December 2021
- 14 December 2021 | Frontiers in Psychiatry, Vol. 12
- Joseph R. Calabrese,
M.D. , - Suresh Durgam,
M.D. , - Andrew Satlin,
M.D. , - Kimberly E. Vanover,
Ph.D. , - Robert E. Davis,
Ph.D. , - Richard Chen,
Ph.D. , - Susan G. Kozauer,
M.D. , - Sharon Mates,
Ph.D. , - Gary S. Sachs,
M.D.
23 September 2021 | American Journal of Psychiatry, Vol. 178, No. 12- Joseph R. Calabrese,
- 11 May 2021 | BMC Psychiatry, Vol. 21, No. 1
- 2 September 2021 | BJPsych Advances, Vol. 3
- 7 June 2021 | Current Medical Research and Opinion, Vol. 37, No. 9
- 26 March 2021 | Expert Opinion on Pharmacotherapy, Vol. 22, No. 10
- Journal of Clinical Psychopharmacology, Vol. 41, No. 4
- Journal of Affective Disorders, Vol. 288
- Journal of Affective Disorders, Vol. 286
- 20 November 2020 | International Clinical Psychopharmacology, Vol. 36, No. 2
- 22 December 2020 | Australian & New Zealand Journal of Psychiatry, Vol. 55, No. 1
- 1 May 2021 | Drug Design, Development and Therapy, Vol. Volume 15
- 14 January 2021 | Biomolecules, Vol. 11, No. 1
- 17 July 2020 | Psychiatry and Clinical Neurosciences, Vol. 74, No. 9
- 2 October 2019 | CNS Spectrums, Vol. 25, No. 4
- Journal of Clinical Psychopharmacology, Vol. 40, No. 4
- 20 May 2020 | Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Vol. 40, No. 6
- 6 November 2019 | Bipolar Disorders, Vol. 22, No. 4
- 19 November 2019 | Bipolar Disorders, Vol. 22, No. 4
- Journal of Child and Adolescent Psychopharmacology, Vol. 30, No. 4
- International Clinical Psychopharmacology, Vol. 35, No. 3
- Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 99
- 12 March 2020 | Expert Opinion on Drug Safety, Vol. 19, No. 3
- 15 January 2020 | Current Behavioral Neuroscience Reports, Vol. 7, No. 1
- 7 January 2020 | Bipolar Disorders, Vol. 22, No. 2
- Journal of Clinical Psychopharmacology, Vol. 40, No. 2
- Journal of Affective Disorders, Vol. 263
- 1 June 2020 | Neuropsychiatric Disease and Treatment, Vol. Volume 16
- 8 August 2019 | Expert Opinion on Drug Safety, Vol. 18, No. 10
- 29 August 2019 | Drugs, Vol. 79, No. 15
- Journal of Affective Disorders, Vol. 257
- 23 May 2019 | Psychiatry and Clinical Neurosciences, Vol. 73, No. 9
- Willie Earley,
M.D. , - Maria Victoria Burgess,
M.D. , - Ludmyla Rekeda,
Ph.D. , - Regan Dickinson,
M.A. , - Balázs Szatmári,
Ph.D. , - György Németh,
M.D. ,Ph.D. , - Roger S. McIntyre,
M.D. ,F.R.C.P.C. , - Gary S. Sachs,
M.D. , - Lakshmi N. Yatham,
M.B.B.S. ,F.R.C.P.C.
8 March 2019 | American Journal of Psychiatry, Vol. 176, No. 6- Willie Earley,
- 7 May 2019 | CNS Drugs, Vol. 33, No. 6
- 20 February 2019 | Expert Review of Neurotherapeutics, Vol. 19, No. 4
- 2 January 2019 | Current Treatment Options in Psychiatry, Vol. 6, No. 1
- Psychiatric Annals, Vol. 49, No. 3
- 15 March 2018 | Journal of Psychopharmacology, Vol. 32, No. 4
- 14 March 2018 | Bipolar Disorders, Vol. 20, No. 2
- 3 November 2017 | The World Journal of Biological Psychiatry, Vol. 19, No. 1
- 5 November 2016 | International Journal of Neuropsychopharmacology, Vol. 55
- 15 March 2016 | Journal of Psychopharmacology, Vol. 30, No. 6
- Holly A. Swartz,
M.D. , - Joseph T. Tasosa,
M.D., M.S.
1 March 2016 | American Journal of Psychiatry, Vol. 173, No. 3- Holly A. Swartz,
- 25 April 2016 | Annals of the New York Academy of Sciences, Vol. 1366, No. 1
- Korean Journal of Family Medicine, Vol. 37, No. 3
Editor Spotlight
Metrics
Writing assistance and editorial support for the preparation of this manuscript were provided by Carol Brown, M.S., and Paul Ferguson, M.S., of Prescott Medical Communications Group, Chicago, a contractor of Forest Research Institute, an Allergan affiliate.
History
Received 4 February 2015
Revised 29 May 2015
Accepted 14 August 2015
Published online 6 November 2015
Published in print 1 March 2016